ArticleToxins2025
Bongkrekic Acid and Its Novel Isomers: Separation, Identification, and Determination in Food Matrices.
Article in Toxins, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Complete Genome Analysis and Antimicrobial Mechanism ofMicroorganisms · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The toxicity associated with bongkrekic acid (BKA) is severe due to its chemical structure, which also facilitates high mortality rates; however, its isomer, isobongkrekic acid (iBKA), with only minor structural variance, demonstrates marked differences in toxicity. This discrepancy in structural properties and toxicity highlights that risks have been potentially underestimated within current detection standards for BKAs. In this study, a novel BKA trans isomer at the C8 and C9 double carbon bonds (E-configuration), termed iBKA-neo, was successfully separated and identified. Subsequently, the multiple reaction monitoring parameters and chromatographic conditions for three BKA isomers were optimized, enabling effective separation within 15 min via UHPLC-MS/MS, among which the ammonium positive adduct ions yielded significantly higher response intensities for all BKA isomers than traditional deprotonated molecules. Additionally, distinct differences in the ion ratios between iBKA-neo and BKA were utilized for preliminary screening. On this basis, the extraction and enrichment strategies for BKAs were optimized in food matrices and validated comprehensively with good linearity (0.25-500 μg/kg), a superior limit of quantification (0.25 μg/kg), acceptable recoveries (82.32-114.84%), and stable intraday and interday precision (an RSD less than 12.67%). These findings significantly contribute to ecotoxicology and the formulation of safety standards concerning BKAs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.